MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells
Autophagy has become one of the most important mechanisms of chemotherapy resistance
by supporting the survival of tumor cells under metabolic and therapeutic stress. Here, we …
by supporting the survival of tumor cells under metabolic and therapeutic stress. Here, we …
[HTML][HTML] miR-31 affects colorectal cancer cells by inhibiting autophagy in cancer-associated fibroblasts
X Yang, X Xu, J Zhu, S Zhang, Y Wu, Y Wu, K Zhao… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Autophagy is a double-edged sword in tumor development. Recent studies have found that
miRNAs have an inhibitory effect on the regulation of autophagy. It has been reported that …
miRNAs have an inhibitory effect on the regulation of autophagy. It has been reported that …
miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis
C Zhao, Q Zhao, C Zhang, G Wang, Y Yao, X Huang… - Scientific reports, 2017 - nature.com
Drug resistance, which is closely correlated with an imbalance in apoptosis, endows
colorectal cancer (CRC) with enhanced progression capacity irrespective of the treatment …
colorectal cancer (CRC) with enhanced progression capacity irrespective of the treatment …
[HTML][HTML] The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer
W Sun, J Li, L Zhou, J Han, R Liu, H Zhang, T Ning… - Theranostics, 2020 - ncbi.nlm.nih.gov
Oxaliplatin (OXA) resistance is the major obstacle to the anticancer effects of chemotherapy
in colorectal cancer (CRC) patients. MicroRNAs (miRNAs) play an important role in the …
in colorectal cancer (CRC) patients. MicroRNAs (miRNAs) play an important role in the …
miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells
X Meng, R Fu - OncoTargets and therapy, 2018 - Taylor & Francis
Introduction Previous studies have found that miRNAs play a key role in drug resistance.
Multiple reports show that miRNAs act as regulators in colorectal cancer (CRC) cells, but the …
Multiple reports show that miRNAs act as regulators in colorectal cancer (CRC) cells, but the …
miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2
Y An, Z Zhang, Y Shang, X Jiang, J Dong, P Yu… - Cell Death & …, 2015 - nature.com
Chemotherapy is an important treatment modality for gastric cancer (GC); however, it usually
fails because of drug resistance, especially multidrug resistance (MDR). Previously, we …
fails because of drug resistance, especially multidrug resistance (MDR). Previously, we …
METTL14-dependent maturation of pri-miR-17 regulates mitochondrial homeostasis and induces chemoresistance in colorectal cancer
K Sun, L Chen, Y Li, B Huang, Q Yan, C Wu, Q Lai… - Cell Death & …, 2023 - nature.com
Abstract miR-17-5p has been found to be involved in the proliferation and metastasis of
colorectal cancer (CRC), and N 6-methyladenosine (m6A) modification is the most common …
colorectal cancer (CRC), and N 6-methyladenosine (m6A) modification is the most common …
miR‑221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells
D Liao, T Li, C Ye, L Zeng, H Li… - Experimental and …, 2018 - spandidos-publications.com
Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of
cancer‑associated mortalities worldwide. MicroRNAs (miRNAs/miRs) serve important roles …
cancer‑associated mortalities worldwide. MicroRNAs (miRNAs/miRs) serve important roles …
miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin
J Han, J Li, K Tang, H Zhang, B Guo, N Hou… - Experimental cell …, 2017 - Elsevier
Evidence demonstrate that p53 mutations and microRNAs (miRs) are important components
of 5-FU resistance in colorectal cancer (CRC). miR-338-3p has been reported associated …
of 5-FU resistance in colorectal cancer (CRC). miR-338-3p has been reported associated …
[HTML][HTML] MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway
L Tian, Z Zhao, L Xie, JP Zhu - Oncotarget, 2018 - ncbi.nlm.nih.gov
Gastric cancer is a prevalent cancer and chemotherapy is a main treatment for patients.
Docetaxel is commonly used as a chemotherapeutic drug for gastric cancer patients. With …
Docetaxel is commonly used as a chemotherapeutic drug for gastric cancer patients. With …